| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $368K | -75.3% |
| Cost of Revenue | $536K | -56.2% |
| R&D Expense | $11.3M | -11.5% |
| SG&A Expense | $11.4M | +4.7% |
| Operating Income | -$22.8M | +2.2% |
| Pre-tax Income | -$29.3M | -28.2% |
| Net Income | -$29.3M | -28.2% |
| EPS (Basic) | -$2212.56 | — |
| EPS (Diluted) | -$2212.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $4.6M | +0.0% |
| Inventory | $150K | — |
| Current Assets | $25.6M | +170.1% |
| Total Assets | $30.1M | +130.9% |
| Current Liabilities | $3.5M | +67.7% |
| Total Liabilities | $18.5M | +671.5% |
| Stockholders' Equity | $11.6M | +9.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | +51.3% |
| Capital Expenditures | $1.1M | +0.5% |
| Investing Cash Flow | $2.9M | -53.9% |
| Financing Cash Flow | $26.6M | +334.3% |
| Free Cash Flow | -$10.5M | +48.6% |
| — |